CD61 (ITGB3) Human shRNA Plasmid Kit (Locus ID 3690)
CAT#: TR312082
ITGB3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 3 publications. |
Product images
经常一起买 (2)
CD61 mouse monoclonal antibody, clone OTI5D9
CNY 1,999.00
CNY 3,600.00
Specifications
Product Data | |
Product Name | CD61 (ITGB3) Human shRNA Plasmid Kit (Locus ID 3690) |
Locus ID | 3690 |
UniProt ID | P05106 |
Synonyms | BDPLT2; BDPLT16; BDPLT24; CD61; GP3A; GPIIIa; GT; GT2 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | ITGB3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 3690). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_000212, NM_000212.1, NM_000212.2, BC127666, BC127667, NM_000212.3 |
Summary | The ITGB3 protein product is the integrin beta chain beta 3. Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain. A given chain may combine with multiple partners resulting in different integrins. Integrin beta 3 is found along with the alpha IIb chain in platelets. Integrins are known to participate in cell adhesion as well as cell-surface mediated signalling. [provided by RefSeq, Jul 2008] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (3)
The use of this RNAi has been cited in the following citations: |
---|
Estudio de los mecanismos celulares y moleculares implicados en la adhesión y migración de células de carcinoma pulmonar no microcítico inducidas por TGFß
,Salvo, E;,
Thesis
[ITGB3]
|
Inhibition of tumor-associated avß3 integrin regulates the angiogenic switch by enhancing expression of IGFBP-4 leading to reduced melanoma growth and angiogenesis in vivo
,Contois, LW;Akalu, A;Caron, JM;Tweedie, E;Cretu, A;Henderson, T;Liaw, L;Friesel, R;Vary, C;Brooks, PC;,
Angiogenesis
,PubMed ID 25249331
[ITGB3]
|
Combined targeting of TGF-beta1 and integrin beta3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer
,Salvo, E;Garasa, S;Dotor, J;Morales, X;Peláez, R;Altevogt, P;Rouzaut, A;,
Mol. Cancer
,PubMed ID 24884715
[ITGB3]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...